公司资料
Senseonics 股价、新闻与催化剂
- 股票代码:
- SENS
- 交易所:
- NYSE
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
8.03 USD (+2.82%)
收盘价
最后更新: 2026年8月17日
359M USD
市值
股价为何变动
As of Aug 17, 2026, SENS closed up 2.82% at $8.03. No new same-company headline was identified in the current news window.
公司概览
Implantable Glucose Monitoring
Senseonics develops long-term implantable continuous glucose-monitoring systems for people with diabetes. Its technology places a fluorescence-based sensor under the skin rather than relying on frequently replaced transcutaneous sensors.
Eversense 365
Eversense 365 is designed to provide up to one year of continuous glucose data from a single implanted sensor. A removable external transmitter powers the sensor and sends readings and alerts to a mobile application. Senseonics manufactures the system and now directly manages U.S. commercialization. The company is also transitioning more international sales and marketing activities in-house.
未来催化剂
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。